• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

OMRF is an independent, nonprofit biomedical research institute dedicated to discoveries that make a difference.

  • About
    • General Information
    • Disease Research
    • Education & Outreach
    • Events
    • Careers
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • News Releases
    • Publications
    • On Your Health
    • Bodywork
  • Patients
    • Anti-Aging Studies
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Disease
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Tax Credit
    • Planned Giving
    • Vehicle Donations
    • Why We Give
    • Your Gift at Work
    • Donor Recognition
    • Contact
Home - OMRF News - Archives for experimental treatment

experimental treatment

OMRF brain cancer drug enters clinical trials at OU cancer center

August 7, 2013

OMRF, Stephenson Cancer Center begin tests of experimental compound

Filed Under: Diseases, News, Research News Tagged With: brain cancer, cancer, cancer center, Charles and Peggy Stephenson Cancer Center, clinical trials, drug study, drug trial, experimental treatment, glioblastoma, glioma, ou, Rheal, rheal towner, scientist-news, Stephenson Cancer Center, Towner, university of oklahoma

Experimental MS medication tested at OMRF shows promise

December 8, 2011

Diagnosing and treating multiple sclerosis early leads to better results

Filed Under: Featured News, News Tagged With: experimental treatment, Gabriel, Gabriel Pardo, medications, MS, MS Center of Excellence, multiple sclerosis, Multiple Sclerosis Center of Excellence, Pardo, scientist-news, therapeutics

OMRF and Hough Ear Institute work to prevent hearing loss

December 1, 2011

A new study shows hearing loss affects 1 in 5 Americans 12 and older.

Filed Under: Featured News, News, Research News Tagged With: acute acoustic trauma, experimental treatment, Floyd, hair cells, hearing impaired, hearing loss, Hough Ear Institute, Kopke, Otologic Pharmaceutics, robert floyd, US dept of defense

Before Footer

EEO/AA Employer/Vet/Disabled

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Intranet
Facebook Twitter Instagram Linkedin

Subscribe to OMRF News
  • Contact
  • Careers
  • Donor Privacy
  • Intranet
OMRF Logo
OKLAHOMA MEDICAL RESEARCH FOUNDATION
825 NE 13th St.
Oklahoma City, OK 73104
(405) 271-6673
Charity navigatorUnited WayGive Smart OKCTop Workplace